Madrigal Pharmaceuticals Inc
SWB:YDO1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Madrigal Pharmaceuticals Inc
SWB:YDO1
|
US |
|
M
|
MMG Ltd
F:OMS1
|
AU |
|
C
|
Corning Inc
SWB:GLW
|
US |
|
F
|
Fluidigm Corp
F:FLB
|
US |
|
DCI Indonesia Tbk PT
IDX:DCII
|
ID |
|
S
|
Societe Generale SA
F:SGE
|
FR |
|
Fiserv Inc
NASDAQ:FISV
|
US |
|
Teva Pharmaceutical Industries Ltd
TASE:TEVA
|
IL |
|
M
|
McDonald's Corp
XETRA:MDO
|
US |
|
Information Services Group Inc
NASDAQ:III
|
US |
|
Sanlam Ltd
F:LA6S
|
ZA |
|
Chimera Investment Corp
LSE:0A7B
|
US |
|
Next PLC
F:NXG0
|
UK |
Wall St Price Targets
YDO1 Price Targets Summary
Madrigal Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for YDO1 is 604.56 EUR with a low forecast of 477.99 EUR and a high forecast of 883.81 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is YDO1's stock price target?
Price Target
604.56
EUR
According to Wall Street analysts, the average 1-year price target for YDO1 is 604.56 EUR with a low forecast of 477.99 EUR and a high forecast of 883.81 EUR.
What is the Revenue forecast for Madrigal Pharmaceuticals Inc?
Projected CAGR
27%
Over the last 13 years, the compound annual growth rate for Revenue has been 102%. The projected CAGR for the next 8 years is 27%.
What is the Gross Profit forecast for Madrigal Pharmaceuticals Inc?
Projected CAGR
26%
The compound annual growth rate for Gross Profit over the next 8 years is 26%.
